★ Sign in to follow
CC

Claus Crone Fuglsang

DK·Finanstilsynet DK
Novonesis (Novozymes A/S)
Insider activity · 24 months1 buy1 saleCumulative net flow
Total declarations
9
Company
1
▲ Purchases (7 ops.)
€3.9M
▼ Sales (1 ops.)
€20k

Latest filing published 26 Mar 2026 for Novonesis (Novozymes A/S), €20k.

Filing timeline

BuySale
Claus Crone Fuglsang

Insider track record

Disclosed buys
7
Disclosed sells
1
Signal history

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Claus Crone Fuglsang: trading record in brief

All filings by Claus Crone Fuglsang on record concern Novonesis (Novozymes A/S). In total, 9 filings cover trades dated from 8 September 2020 to 26 March 2026.

On the open market, the record shows 7 purchases worth €3.9M and 1 sale worth €20k. On balance, insiders were net buyers of €3.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at no purchases and 1 sale.

Half of the purchases are above €576k and half below. Across 7 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 26 March 2026 came the latest disclosure, an open-market sale for €20k in Novonesis (Novozymes A/S). The last insider purchase was made public on 10 June 2025, 516 days ago. Publication is fast: at least half of the trades appear on Finanstilsynet DK on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finanstilsynet DK. Past trades are no guide to future returns.

Companies and markets linked to Claus Crone Fuglsang

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▼
    Claus Crone Fuglsang
    ExecutivesNovonesis (Novozymes A/S)
    148,720 DKK2DK FSA
    400 shares@ DKK 371.800.0% of flowShareNasdaq CopenhagenISIN DK0060336014DK:1429237
  • ▲
    Claus Crone Fuglsang
    ExecutivesNovonesis (Novozymes A/S)
    12M DKK2DK FSA
    34,407 shares@ DKK 350.800.1% of flowShareOutside a trading venueISIN DK0060336014DK:1368228
    Canonical exit: 8 Sept 2025 (T+90)
  • ▲
    Claus Crone Fuglsang
    ExecutivesNovonesis (Novozymes A/S)
    6,086 DKK2DK FSA
    13 shares@ DKK 468.160.0% of flowShareOff exchangeISIN DK0060336014DK:1316485
    Canonical exit: 15 Dec 2024 (T+90)
  • ▲
    Claus Crone Fuglsang
    ExecutivesNovonesis (Novozymes A/S)
    937,920 DKK2DK FSA
    3,100 shares@ DKK 302.55470.0% of flowShareNasdaq CopenhagenISIN DK0060336014DK:1244649
    Canonical exit: 23 Nov 2023 (T+90)
  • ▲
    Claus Crone Fuglsang
    CSO and Executive Vice President, Research & DevelopmentExecutivesNovonesis (Novozymes A/S)
    5M DKK11DK FSA
    20,000 shares@ DKK 271.200.0028% mcap0.0% of flowShareISIN DK0060336014DK:1124431
    Canonical exit: 8 Feb 2022 (T+90)
  • ▲
    Claus Crone Fuglsang
    CSO and Executive Vice President, Research & DevelopmentExecutivesNovonesis (Novozymes A/S)
    5M DKK11DK FSA
    17,296 shares@ DKK 271.200.0% of flowShareISIN DK0060336014DK:1030267
    Canonical exit: 4 Aug 2021 (T+90)
  • ▲
    Claus Crone Fuglsang
    Executive Vice President,ExecutivesNovonesis (Novozymes A/S)
    2M DKK11DK FSA
    7,195 shares@ DKK 249.400.0% of flowShareISIN DK0060336014DK:1005046
    Canonical exit: 18 May 2021 (T+90)
  • ●
    Claus Crone Fuglsang
    CSO and Executive Vice President, Research & DevelopmentExecutivesNovonesis (Novozymes A/S)
    818,526 DKK11DK FSA
    2,110 shares@ DKK 387.92680.0004% mcap0.0% of flowShareISIN DK0060336014DK:959514
  • ▲
    Claus Crone Fuglsang
    CSO and Executive Vice President, Research & DevelopmentExecutivesNovonesis (Novozymes A/S)
    4M DKK11DK FSA
    14,943 shares@ DKK 286.95680.0% of flowShareISIN DK0060336014DK:954573
    Canonical exit: 7 Dec 2020 (T+90)

9 of 9 declarations

Related entities

No related entities found.